Zim Laboratories Intrinsic Value
Zim Laboratories (ZIMLAB) median intrinsic value is ₹46.97 from 3 valuation models (range ₹31–₹67), vs current price ₹104.65 — -55.1% downside (Trading Above Calculated Value), margin of safety -100.0%. Also explore ZIMLAB price trends to track price trends across different timeframes.
ZIMLAB Valuation Methods Summary — DCF, Graham Number & P/E
Zim Laboratories intrinsic value across 3 models vs current price ₹104.65 — upside/downside and value range per method. For current market price and key ratios, visit Zim Laboratories share price screener.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹66.88 | ₹53.50 - ₹80.26 | -36.1% | EPS: ₹3.04, Sector P/E: 22x |
| PEG Ratio Method | growth | ₹31.39 | ₹28.25 - ₹34.53 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹46.97 | ₹42.27 - ₹51.67 | -55.1% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
ZIMLAB Intrinsic Value vs Market Price — All Valuation Models
Zim Laboratories fair value range ₹31–₹67 vs current market price ₹104.65 across 3 valuation models. Browse ZIMLAB complete financial statements for revenue, profit, balance sheet and cash flow data.
ZIMLAB Intrinsic Value Analysis — Undervalued or Overvalued?
Zim Laboratories median intrinsic value ₹46.97, current price ₹104.65 — Trading Above Calculated Value by 55.1%, margin of safety -100.0%.
What is the intrinsic value of ZIMLAB?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Zim Laboratories (ZIMLAB) is ₹46.97 (median value). With the current market price of ₹104.65, this represents a -55.1% variance from our estimated fair value.
The valuation range spans from ₹31.39 to ₹66.88, indicating ₹31.39 - ₹66.88.
Is ZIMLAB undervalued or overvalued?
Based on our multi-method analysis, Zim Laboratories (ZIMLAB) appears to be trading above calculated value by approximately 55.1%.
ZIMLAB Financial Health — Key Ratios vs Industry Benchmarks
Zim Laboratories financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Operating Margin | 7.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
ZIMLAB Cash Flow Quality — Operating & Free Cash Flow
Zim Laboratories operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹50 Cr | ₹23 Cr | Positive Free Cash Flow | 7/10 |
| March 2025 | ₹41 Cr | ₹21 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹16 Cr | ₹-21 Cr | Positive Operating Cash Flow | 6/10 |
| March 2023 | ₹38 Cr | ₹20 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹49 Cr | ₹42 Cr | Positive Free Cash Flow | 8/10 |